Impact of autologous mitochondrial transfer on obstetric and neonatal health of offspring: A small single-center case series.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Gil J
  • Nohales M
  • Serra V
  • Labarta E

Grupos

Abstract

INTRODUCTION: A pilot study was carried out to test the efficacy of the autologous mitochondrial transfer therapy (AUGMENT) technique. No improvements in pregnancy rate, development, or embryo quality were observed in the AUGMENT-treated group versus the Control group in this study. The main objective of this research is to analyze whether AUGMENT technology did have any impact on the obstetric and perinatal outcomes of pregnancies and children resulting from treated oocytes. METHODS: Follow up study of women with a livebirth who participated in a pilot randomized controlled trial in which sibling MII oocytes were randomly allocated to AUGMENT + intracytoplasmic sperm injection (ICSI) (AUGMENT group) or ICSI alone (control group). Preimplantation genetic testing for aneuploidy was performed in both groups. Pregnancy and neonatal outcomes of 14 women (15 pregnancies) and their 18 children were analyzed. The information was retrieved by reviewing the medical records or through questionnaires sent to the patients. RESULTS: No differences were found in this small case series between the AUGMENT and control groups regarding the rate of gestational complications, birth defects, gestational age at delivery (271.4 ± 12.56 vs 278 ± 10.4 days), birthweight (3.1 ± 0.6 kg vs. 3.1 ± 0.4 kg) and neonatal outcome. DISCUSSION: The few pregnancies achieved using AUGMENT oocyte therapy had similar outcomes than controls in this very small series. Our very preliminary data need to be confirmed in larger samples. The long term follow up of these children also needs to be analyzed.

Copyright © 2024. Published by Elsevier Ltd.

Datos de la publicación

ISSN/ISSNe:
0143-4004, 1532-3102

Placenta  W B SAUNDERS CO LTD

Tipo:
Article
Páginas:
217-222
PubMed:
39500015
Factor de Impacto:
0,840 SCImago
Cuartil:
Q1 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • AUGMENT; Mitochondrial transfer; Pregnancy

Campos de Estudio

Proyectos y Estudios Clínicos

Contrato PFIS 2021. Ángel Martín

Investigador Principal: MARÍA JOSÉ DE LOS SANTOS MOLINA

FI21/00096 . INSTITUTO DE SALUD CARLOS III . 2022

Estudio del método de selección espermática ZyMot y su efecto en la ploidía del embrión en pacientes de edad materna avanzada

Investigador Principal: MARÍA JOSÉ DE LOS SANTOS MOLINA

PI23/00737 . INSTITUTO DE SALUD CARLOS III . 2024

Cita

Compartir